Advertisement
Advertisement

CRGX

CRGX logo

CARGO Therapeutics Inc

13.92
USD
-0.84
-5.69%
Dec 18, 13:53 UTC -5
Open

CARGO Therapeutics Inc Profile

About

CARGO Therapeutics Inc. is a clinical-stage biotechnology company, develops chimeric antigen receptor (CAR) T-cell therapies for cancer patients. The company's lead program is CRG-022 and CRG-023. CARGO Therapeutics Inc. is based in San Mateo, California.

Info & Links

CEO

Gina Chapman

Headquarters

1900 Alameda Las Pulgas, Suite 350
SAN MATEO, CA 94403, UNITED STATES

Auditor

Deloitte & Touche LLP

Share holders

44

Employees

116

CARGO Therapeutics Inc Statistics

Valuation Measures

Market Capitalization2

640.74M

Enterprise Value

569.56M

Enterprise Value/EBITDA(ttm)

-3.44

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

1.57

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-38.16%

Return on Invested Capital(ttm)

-38.13%

Return on Assets(ttm)

-33.94%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-165.38M

Net Income Available to Common(ttm)

-154.14M

Diluted EPS(ttm)

-4.26

Share Statistics

Beta (5Y Monthly)

--

52-Week Change

-11.00%

S&P 500 52-Week Change

27.87%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

46.03M

Dividend Yield

0.00%

Float4

45.39M

% Held by Insiders

1.38%

% Held by Institutions

93.16%

Balance Sheet

Total Cash(mrq)

404.85M

Total Cash Per Share(mrq)

8.80

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

18.95%

Quick Ratio(mrq)

18.95%

Book Value Per Share(mrq)

8.72

Cash Flow

Operating Cash Flow Per Share(ytd)

-2.20

Free Cash Flow(ytd)

-108.45M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement